Le Lézard
Classified in: Health
Subjects: WOM, MAT

Suria Plastic Surgery & Medspa First to Bring Cliovanatm to Miami/Ft. Lauderdale/Palm Beach


DENVER, July 10, 2020 /PRNewswire-PRWeb/ -- A prominent leader in female health and wellness, and a board-certified gynecologist, Dr. Lillian DeCosimo in partnership with Dr. Shashi Kusuma, a plastic surgeon, is introducing Cliovana to the Miami/Ft. Lauderdale/Palm Beach markets in conjunction with the launch of Suria Women's Health division. This service/treatment is a first-of-its-kind specifically focused on female arousal and pleasure and will be offered at both Suria Plastic Surgery in Plantation & Suria Plastic Surgery & Medspa in Boca Raton.

Truly satisfying sex is an important part of a woman's overall physical and emotional well-being at any age. However many women don't experience these feelings and derive as much pleasure as they can and should in their lives. Cliovana is a simple and completely non-invasive way to increase women's arousal levels and orgasm frequency and intensity. Cliovana does not use lasers, scalpels or needles, so there are no dangerous side effects.

Dr. DeCosimo describes Suria Plastic Surgery & Medspa and now the Suria Women's Health division as a Surgical aesthetic and wellness practice dedicated to helping women renew their passion for life as they age. Her practice also offers women at all stages of their lives well-woman exams, menopause and Bio-identical hormone replacement counseling and treatment, evaluation and treatment of female sexual desire issues, and cosmetic procedures of the genital area. Many women want to get more out of sex, but they want to do it in a way that respects their body. Cliovana is the perfect solution because it enhances arousal at the cellular level, and causes your body to do more of what it does naturally - regenerate cells.

So how does Cliovana work? The body is always regenerating cells. Cliovana stimulates the body to do more of that, specifically in the genitals, that in turn can lead to an increase in women's long term sexual responsiveness. The technologies employed by Cliovana have been used for decades, all over the world, for a variety of health issues. The treatment is a total of four sessions at less than 10 minutes each, over the course of 2 weeks. Because it is 100% noninvasive, there is zero downtime.

Enjoy life. Live well. Look good and feel great at any age.

Learn more about Cliovana
https://cliovana.com
[email protected]
1-833-818-2546
@cliovana

About Dr. Lillia DeCosimo and Suria Plastic Surgery & MedSpa
Dr. Lillian M. DeCosimo is an experienced Board Certified Gynecologist and a fellow of the American College of Obstetrics & Gynecology who has been in women's healthcare for 25 years. Throughout her career, she developed a particular interest and expertise in the maintenance of women's wellness, female sexual health, management of perimenopause, menopause, Bio-identical hormone replacement therapy and feminine aesthetic services.

Dr. DeCosimo speaks multiple languages including Spanish. She aims to build a women's wellness and health center of excellence and offers Bioidentical hormone replacement therapy, treatments for Sexual Dysfunction, and Urinary Incontinence. She will also collaborate with Dr. Kusuma and together will offer Cosmetic Gynecology services.

 

SOURCE Cliovana


These press releases may also interest you

at 23:38
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...

at 23:33
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...

at 22:54
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....

at 22:03
The report titled "Progressive Familial Intrahepatic Cholestasis Treatment Market by Drug Type (Cholestyramine, Rifampicin, Ursodeoxycholic Acid), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies), End-Users - Global...

at 20:35
RevolKa Ltd. (Norio Hamamatsu, President & CEO), a venture-backed biotech company providing a game-changing protein engineering technology platform and La Jolla Institute for Immunology (LJI) (Erica Saphire, President & CEO) agreed to start a...

at 19:05
Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ENTYVIOŽ (vedolizumab) subcutaneous (SC) administration for maintenance therapy in adults with moderately to severely active Crohn's disease (CD)...



News published on and distributed by: